Review



phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes)  (Full Moon BioSystems)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Full Moon BioSystems phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes)
    Phospho Explorer Antibody Array Containing 1318 Antibodies (With 99% Reactivity Against Human Epitopes), supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+antibody+array/phospho+explorer+antibody+array/pmc11937680-381-5-16
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes) - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Microarray:

    Article Title: MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma.
    Article Snippet: The Phospho Explorer antibody microarray, which was designed and manufactured by Full Moon Biosystems, Inc. (Sunnyvale, CA, USA), contains 1318 antibodies. .. The Phospho Explorer antibody microarray, which was designed and manufactured by Full Moon Biosystems, Inc. (Sunnyvale, CA, USA), contains 1318 antibodies. .. The antibody array experiment was performed via Full Moon Biosystems, according to their established protocol.

    Ab Array:

    Article Title: Phenotypic Screening Identifies Flunarizine as an Inhibitor of Radiotherapy-Induced Astrocyte Reactivity with Therapeutic Potential in Glioblastoma
    Article Snippet: .. The Phospho Explorer antibody array (PEX100, Full Moon Biosystems) was performed according to the manufacturer’s protocol using primary human astrocytes, either irradiated or non-irradiated. .. Slides were scanned using an INNOPSYS InnoScan Microarray scanner and signal intensity data for each spot on the array were extracted from the images.

    Article Title: Maternal Myo-Inositol Deficiency Involved Autophagy Impairment by PI3K/Akt/mTOR Signaling in Neural Tube Defects During Pregnancy.
    Article Snippet: Previous studies have demonstrated that peri-conceptional inositol supplementation could effectively ameliorate the recurrence of neural tube defects (NTDs); though, the mechanism remains unclear.. In the current investigation, we detected the myo-inositol (MI) levels in maternal plasma and embryonic tissues in a Chinese population with high prevalence of NTDs and found maternal MI deficiency increased NTD susceptibility in this area.. Pregnant mice were randomly divided into 2 groups.

    Article Title: Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells.
    Article Snippet: .. To investigate NINJ2 signaling, we examined a phosphoprotein antibody array (PEX100, Fullmoon Biosystems, Sunnyvale, CA, USA) containing 1,318 site-specific and phospho-specific antibodies, with 2 replicates per antibody, in NINJ2-overexpressing MKN-74 cells. .. The phospho-protein antibody array was performed according to the manufacturer’s instructions (Fullmoon Biosystems).

    Irradiation:

    Article Title: Phenotypic Screening Identifies Flunarizine as an Inhibitor of Radiotherapy-Induced Astrocyte Reactivity with Therapeutic Potential in Glioblastoma
    Article Snippet: .. The Phospho Explorer antibody array (PEX100, Full Moon Biosystems) was performed according to the manufacturer’s protocol using primary human astrocytes, either irradiated or non-irradiated. .. Slides were scanned using an INNOPSYS InnoScan Microarray scanner and signal intensity data for each spot on the array were extracted from the images.

    other:

    Article Title: Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy.
    Article Snippet: The PEX100 antibodymicroarray (Full Moon BioSystems, Inc, Sunnyvale, CA, USA) was scanned by GenePix 4000B (Axon Instruments, USA) and analyzed by GenePixTM Pro 6.0 (Axon Instruments, USA).

    Article Title: Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells.
    Article Snippet: The phospho-protein antibody array was performed according to the manufacturer’s instructions (Fullmoon Biosystems).

    Article Title: Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells
    Article Snippet: To investigate NINJ2 signaling, we examined a phospho-protein antibody array (PEX100, Fullmoon Biosystems, Sunnyvale, CA, USA) containing 1,318 site-specific and phospho-specific antibodies, with 2 replicates per antibody, in NINJ2-overexpressing MKN-74 cells.



    Similar Products

    phospho explorer antibody array pex100  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array pex100
    Phospho Explorer Antibody Array Pex100, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+antibody+array/phospho+explorer+antibody+array/bio_rxiv__2025__07__12__664538-56-1-6
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array pex100 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody arrays  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody arrays
    Phospho Explorer Antibody Arrays, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+antibody+array/phospho+explorer+antibody+array/10__1016_slash_j__phymed__2025__156660-98-1-8
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody arrays - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes)  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes)
    Phospho Explorer Antibody Array Containing 1318 Antibodies (With 99% Reactivity Against Human Epitopes), supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+antibody+array/phospho+explorer+antibody+array/pmc11937680-381-5-16
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody array cat. no. pex100  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array cat. no. pex100
    Phospho Explorer Antibody Array Cat. No. Pex100, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+antibody+array/phospho+explorer+antibody+array/10__1007_slash_s10068___025___01822___1-108-7-14
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array cat. no. pex100 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody array  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array
    <t>Proteomic</t> profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.
    Phospho Explorer Antibody Array, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+antibody+array/phospho+explorer+antibody+array/pmc11977646-108-0-11
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Proteomic profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.

    Journal: Molecular Oncology

    Article Title: Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis

    doi: 10.1002/1878-0261.13788

    Figure Lengend Snippet: Proteomic profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.

    Article Snippet: Proteomic expression analyses were done using the Phospho Explorer Antibody Array (Full Moon Biosystems, TebuBio, Le Perray en Yvelines, France).

    Techniques: Expressing, Selection, Comparison